Squarepoint
ABMD

Squarepoint’s Abiomed Inc ABMD Stock Holding History

Squarepoint’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,500
Closed -$1.12M – 3895
2021
Q1 		$1.12M Buy
+3,500
New +$1.12M 0.01% 1421

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Squarepoint's ABMD Position: Q4 2022 in Review

Squarepoint sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 18,763 shares — an estimated $4.61M sold.

Squarepoint first reported a position in ABMD in Q2 2016 and held it in 15 quarters. The position peaked at $10.2M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Squarepoint reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Squarepoint sold 18,763 Abiomed Inc shares in Q4 2022, an estimated $4.61M.
  • Squarepoint first reported a position in Abiomed Inc in Q2 2016 and held it in 15 quarters.
  • Squarepoint's Abiomed Inc position peaked at $10.2M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.